The clinical effect of combination therapy with edaravone and sodium ozagrel for acute cerebral infarction

Brain and Nerve

Volumn 55, Issue 7, 2003, Pages 589-593

  Takabatake, Yasushi ^a   Uno, Eiichi ^a   Wakamatsu, Kouichi ^a   Yamazaki, Noriaki ^a   Hashimoto, Norichika ^a   Tsuchiya, Yoshitake ^a  

^a FUKUI KEN SAISEIKAI HOSPITAL   (Japan)

Author keywords

Acute cerebral infarction; Edaravone; Sodium ozagrel

Indexed keywords

NORPHENAZONE; OZAGREL; THROMBOXANE A2 RECEPTOR BLOCKING AGENT;

ARTICLE; BRAIN INFARCTION; CEREBROVASCULAR ACCIDENT; COMBINATION CHEMOTHERAPY; DRUG CONTRAINDICATION; DRUG EFFICACY; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; RATING SCALE; RETROSPECTIVE STUDY; THROMBOEMBOLISM; TREATMENT OUTCOME;

AGED; ANTIPYRINE; CEREBRAL INFARCTION; DRUG THERAPY, COMBINATION; FEMALE; FIBRINOLYTIC AGENTS; FREE RADICAL SCAVENGERS; HUMANS; MALE; METHACRYLATES; MIDDLE AGED; TREATMENT OUTCOME;

EID: 0042567292     PISSN: 00068969     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Abe K, Yuki S, Kogure K: Strong attenuation of ischemic and postischemic brain edema in rats by a novel free radical scavenger. Stroke 19: 480-485, 1988
2. Nishi H, Watanabe T, Sakurai H, Yuki S, Ishibashi A: Effect of MCI-186 on brain edema in rats. Stroke 20: 1236-1240, 1989
3. Watanabe T, Yuki S, Egawa M, Nishi H: Protective effects of MCI-186 on cerebral ischemia: Possible involvement of free radical scavenging and antioxidant actions. J Pharmacol Exp Ther 268: 1597-1604, 1994
4. Special report from the National Institute of Neurological Disorders and Stroke: Classification of cerebrovascular diseases III. Stroke 21: 637-376, 1990